Supreme Court Demanded Patanjali to Provide “Research, Evidence” Against Misleading Advertisements, Stating Zero Tolerance.
Thank you for reading this post, don't forget to subscribe!
NEW DELHI: Today (27 Feb), the Supreme Court strongly criticized Patanjali Ayurved for its ‘misleading’ advertisements and enforced a total prohibition on the company from disseminating any product advertisements associated with illnesses or medical conditions.
This ruling follows a petition filed by the Indian Medical Association concerning Patanjali Ayurved’s ‘misleading’ advertisements.
During the hearing, Justices Hima Kohli and A. Amanullah criticised Patanjali Ayurved for releasing advertisements despite previous court orders.
“The entire country has been taken for a ride! For two years you wait when Drugs Act says this is prohibited?”
-the Court remarked.
The SC has served a contempt of court notice to Patanjali Ayurved and Acharya Balakrishnan for their deceptive advertisements across different media channels, granting them a three-week window to respond.
In November 2023 as well, the Supreme Court warned Patanjali that it would be fined Rs 1 crore if a false claim is made that its products can “cure” certain diseases.
During the hearing, the bench questioned the actions taken by the Ministry of Ayush in response to the misleading advertisements.
The Additional Solicitor General (ASG) said that data was being collected on complaints and violations by Patanjali Ayurved. However, the bench expressed dissatisfaction with the ministry’s response, urging urgent action and self-monitoring regarding such advertisements.
FOLLOW US ON YOUTUBE FOR MORE LEGAL UPDATES
